Investor profile
Andera Partners has backed 20 European tech companies across 26 funding rounds between 2018 and 2026, joining rounds totalling €1.8B. Most active in Healthtech and Energy. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 2 | €368M |
| HR Path | France | 3 | €325M |
| Fire1 | Ireland | 2 | €139M |
| Amolyt Pharma | France | 1 | €129M |
| Mylight150 | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Fire1 | Other | €115M | 2025-01 |
| HR Path |
| 1 |
| €100M |
| Artios | UK | 1 | €99M |
| Imcheck Therapeutics | France | 1 | €96M |
| T-knife | Germany | 1 | €93M |
| Grey Wolf Therapeutics | UK | 2 | €87M |
| Exciva | Germany | 2 | €60M |
| SoniVie | Italy | 1 | €56M |
| Qovoltis | France | 1 | €45M |
| Bioptimus | France | 1 | €40M |
| TargED Biopharmaceutical | Netherlands | 1 | €39M |
| TargED Biopharmaceuticals | Netherlands | 1 | €39M |
| HighLife | France | 1 | €32M |
| Ingenostrum | Spain | 1 | €25M |
| Medical microinstruments | Italy | 1 | €20M |
| Skysun | Belgium | 1 | €17M |
| Klubb | France | 1 | €0 |
| Other |
| €113M |
| 2022-05 |
| HR Path | Debt | €113M | 2022-05 |
| HR Path | Other | €100M | 2019-04 |
| Mylight150 | Other | €100M | 2023-11 |
| Artios | Series D+ | €99M | 2025-11 |
| Imcheck Therapeutics | Other | €96M | 2022-06 |
| T-knife | Series B | €93M | 2021-08 |
